Jeremie Calais, MD, PhD

Jeremie Calais, MD, PhD, discusses controversies and unresolved questions in the treatment of patients with prostate cancer.

Jeremie Calais, MD, MSc, discusses the role of prostate-specific membrane antigen-PET imaging in metastatic-castrate resistant prostate cancer, and touches on the importance of integrating PSMA-PET imaging into community settings for clinical practice.

In a recent study, investigators at UCLA and UCSF have demonstrated high positive predictive value for a new imaging technique for localizing recurrent prostate cancer.